DANIELLE WEBSTER: Open Payments
NPI 1508499252 · PRAIRIEVILLE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,937 in 193 payments from 21 companies in 2025. Trend: 2023 $1,247 · 2024 $2,780 · 2025 $3,937
Food & beverage: $3,694Education: $243
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 57 | $867 |
| GENZYME CORPORATION | 20 | $581 |
| Janssen Biotech, Inc. | 19 | $440 |
| Regeneron Healthcare Solutions, Inc. | 12 | $355 |
| UCB, Inc. | 15 | $327 |
| Lilly USA, LLC | 15 | $262 |
| PFIZER INC. | 23 | $240 |
| Incyte Corporation | 8 | $228 |
| Organon LLC | 4 | $173 |
| Novartis Pharmaceuticals Corporation | 3 | $74 |
Products named: DUPIXENT, SKYRIZI, TREMFYA, Bimzelx, CIBINQO, TALTZ, Opzelura, RINVOQ.
Industry payments across LA — which companies pay providers there.
